For decades, severe spinal cord injury has meant living with the possibility of permanent paralysis.
Now, regenerative medicine is opening a new chapter.
Researchers in Japan have been studying a remarkable approach using induced pluripotent stem cells (iPSCs).These cells can be transformed into neural stem/progenitor cells. They are then transplanted into the injured spinal cord, with the hope of supporting damaged neural pathways and restoring function.
In a first-in-human clinical study at Keio University, four patients with severe subacute spinal cord injuries received the treatment. Around 2 million iPS cell-derived neural progenitor cells were transplanted into the injured area.
The early results were encouraging.
At 52 weeks, the median improvement in motor function was 13 points on the ISNCSCI motor score. One patient improved from AIS Grade A to C, while another improved from Grade A to D.
The results are promising.
But they are not a cure yet.
The study involved only four patients. Larger and controlled studies are still needed to determine how effective the treatment truly is.What makes this development meaningful is not just the technology.
It is the possibility of giving damaged nervous systems another chance to reconnect.Medicine has often focused on managing what cannot be repaired.
Regenerative medicine asks a different question:-What if some of the damage we once considered permanent could one day be repaired?
MBH/PS